Share Price, page-78

First 78 Last

Share
Profile

Follow
Merchant2000

21,297 Posts.

881

28/06/19

09:17

Post #: 39281003
Share

Originally posted by qqqqqqqqq: ↑

Risky you make some very good points

Yes you make a good point about the hand that feeds companies etc...

IMO
As a potential investor at this point in time - I must keep my emotions out as this is a stock market site for making money

Emotions and investing do not mix unfortunately. There is a general site for discussing other issues not pertaining to investing

The stock market and Big pharmas are a business and those investing are here or there there to make money

IMO

One should research both the NDF and Edison reports for full valuations and full assumptions and expected $11m -$15m capital required to complete phase 2 studies

Licence agreement and milestones area also important and any possible capital raises required

Why is the share price at these levels ??? with at least 4 trials in progress etc...

Who has been selling at these levels in recent times and days if its not P hopper ???

They say fully funded until end of 2019 - which is great but as below looks like at least another 12 months until registration study commences etc

Company announcement

''We should mostly finish the ongoing phase IIa study towards the end of this year. We are already well-advanced in preparation for a registration study that will hopefully start in the first half of 2020. ''

Lets hope that going forward GDC0084 delivers the results to help all those suffering this most deadly and complex disease

DYOR

Good Luck All

Expand

imo
I don’t think anyone with experience or knowledge of how the market works would believe that P Hopper selling a tiny 200k shares or so is responsible for the near 25 year lows in share price

Past two days have been a few larger sell downs ???

Roche Ltd is capitalised at $240 billion - that’s a big pharma imo

KZA Price at posting: 35.0¢ Sentiment: None Disclosure: Not Held
2 Upvote

0 Great analysis

Reply

Top Stories

Week 35 Wrap: HotCopper’s top watched; ‘iron ore winter’ has started; Oz inflation @ 3.5% MoM; Harris fracking flip

Consumer Staples Shine Amid Retail Slump – Key Stocks to Watch

TBN

Tamboran kicks off Shenandoah South pilot project with SS-2H well spud

LLC

Lendlease sells off US east coast construction operations in latest global divestment push

HLX

Helix investor makes partial takeover bid, proposing board changes

CYM

WA Nifty copper project steps closer to restart with Cyprium Metals inking $40M loan from Glencore

VYS

Vysarn acquires Waste Water Services Pty Ltd for $7.5M; WWS to become subsidiary as expansion continues

PYC

PYC achieves key designation for drug aiming to treat blinding eye disease ADOA

CCO

The Calmer Co’s Anthony Noble reflects on record breaking FY24

HVN

Consumers cautious according to Harvey Norman, as profit slumps 35% in FY24

There are more pages in this discussion • 60 more messages in this thread...

First 78 Last

Add KZA (ASX) to my watchlist

Share Price, page-78

Top Stories

Week 35 Wrap: HotCopper’s top watched; ‘iron ore winter’ has started; Oz inflation @ 3.5% MoM; Harris fracking flip

Consumer Staples Shine Amid Retail Slump – Key Stocks to Watch

Tamboran kicks off Shenandoah South pilot project with SS-2H well spud

Lendlease sells off US east coast construction operations in latest global divestment push

Helix investor makes partial takeover bid, proposing board changes

WA Nifty copper project steps closer to restart with Cyprium Metals inking $40M loan from Glencore

Vysarn acquires Waste Water Services Pty Ltd for $7.5M; WWS to become subsidiary as expansion continues

PYC achieves key designation for drug aiming to treat blinding eye disease ADOA

The Calmer Co’s Anthony Noble reflects on record breaking FY24

Consumers cautious according to Harvey Norman, as profit slumps 35% in FY24

Featured News